Axonics Inc

+3.10 (+4.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.59B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$63.7 Million
Adjusted EPS-$0.47
See more estimates
10-Day MA$71.12
50-Day MA$71.12
200-Day MA$59.16
See more pivots

Axonics Inc Stock, NASDAQ:AXNX

26 Technology Drive, Irvine, California 92618
United States of America
Phone: +1.949.396.6322
Number of Employees: 517


Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.